THE CONTROVERSIAL Kelly Martin has made his mark on the Irish investment scene. Having debuted just on 20 years ago when he was parachuted in to rescue Elan Pharmaceuticals, he has reached what looks like a final chapter here by walking away from an €18.5m legal action that he initiated, alongside fellow Malin Corp founders… Read more »
To access this content, you must be a Phoenix subscriber.
Get access to The Phoenix online for as low as €1.50 per week. Read all the regular online only Phoenix stories AND receive the packed digital edition every fortnight (25 per year). Great value for so many inside stories!